Latest Tissue plasminogen activator Stories
THR-18 significantly decreases the occurrence of intracranial hemorrhage and brain edema, and enhances recovery in acute ischemic stroke patients REHOVOT, Israel, December 18, 2014 /PRNewswire/
Swedish Medical Center leads the way in effectively treating nation's fourth leading cause of death DENVER, Dec.
Study is most significant stroke treatment clinical trial since NINDS-2 says Society of NeuroInterventional Surgery WASHINGTON, Dec.
Leader in Emergency Medicine and Medical Ventures NEW YORK, Nov. 11, 2014 /PRNewswire/ -- Vesselon, Inc. today announced the appointment of Paul S.
Initial data show that THR-18 significantly decreases the occurrence of intracranial hemorrhage (ICH) and brain edema in acute ischemic stroke (AIS) patients REHOVOT, Israel, November 4, 2014
Sonic hedgehog plays important role in reducing stroke size and promoting nerve regeneration SACRAMENTO, Calif.
Patents granted for innovative minimally invasive technology for Acute Ischemic Stroke treatment, strengthening Neuravi's patent portfolio. Galway, Ireland
Experienced in European and Global Medical Technology Launches NEW YORK, Sept 23, 2014 /PRNewswire/ -- Vesselon, Inc.
Enrollment in Worldwide Trial Continues as Planned REDMOND, Wash., Sept.
Many more stroke patients could benefit from thrombolytic treatment (the use of drugs to break up or dissolve blood clots), but it needs to be administered as quickly as possible after the first signs of illness.
- A transitional zone between two communities containing the characteristic species of each.